Skip to content
OpenCapital
Get started

NeoGenomics NEO Reportable Segment — NET REVENUE

Similar metrics at other companies

Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — Net revenue
$317M+19.2%
ARH
ARHSReportable Segment — Net revenue
$314.28M+0.9%
Yelp logo
YELPReportable Segment — Net revenue
$361.46M+0.8%
Mama's Creations, Inc. logo
MAMAReportable Segment — Net Sales
$52.77M+49.7%
YETI Holdings, Inc. logo
YETIReportable Segment — Net Sales
$380.41M+8.3%
SIT
SITEReportable Segment — Net Sales
$940.1M+0.1%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's reportable segment — net revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's reportable segment — NET REVENUE?
NeoGenomics (NEO) reported reportable segment — NET REVENUE of $186.67M in Q1 2026.
How has NeoGenomics's reportable segment — NET REVENUE changed year-over-year?
NeoGenomics's reportable segment — NET REVENUE increased by 11.1% year-over-year, from $168.04M to $186.67M.
What is the long-term trend for NeoGenomics's reportable segment — NET REVENUE?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — NET REVENUE has grown at a 12.6% compound annual growth rate (CAGR), from $509.73M to $727.33M.
What does reportable segment — NET REVENUE mean?
Represents the total gross revenue generated by the business segment after deducting returns, allowances, and discounts. This metric serves as the primary indicator of the segment's market demand and top-line growth performance.